Box 5
Container
Contains 62 Results:
Human adenosine deaminase gene transduced autologous T-lymphocytes (ADA-transduced T lymphocytes) - annual report to FDA, 1991
File — Box: 5, Folder: 35
Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency (ADA) with autologous lymphocytes transduced with a human ADA gene - patient consent form, circa 1990
File — Box: 5, Folder: 36
Dates:
circa 1990
Children's assent form [for ADA-SCID protocol], circa 1990
File — Box: 5, Folder: 37
Dates:
circa 1990
GTI supernatant request form, 1990
File — Box: 5, Folder: 38
Information for ADA-SCID gene therapy patients - drafts, 1990
File — Box: 5, Folder: 39
Selection of ADA-SCID patients, 1990
File — Box: 5, Folder: 40
DeSilva patient name labels, 1990
File — Box: 5, Folder: 41
DeSilva schedule, 1990
File — Box: 5, Folder: 42
Cindy Cutshall - schedule, 1990
File — Box: 5, Folder: 43
Rainbow patients are first candidates for new gene transplants - news release, 2 August 1990
File — Box: 5, Folder: 44